• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER ORTHOPAEDICS-MAHWAH 28MM +8 V40 TAPER VIT HEAD; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, CEMENTED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER ORTHOPAEDICS-MAHWAH 28MM +8 V40 TAPER VIT HEAD; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, CEMENTED Back to Search Results
Catalog Number 6260-5-328
Medical Device Problem Codes Degraded (1153); Insufficient Device Problem Information (3190)
Health Effect - Clinical Codes Inflammation (1932); Injury (2348); Joint Dislocation (2374); Reaction (2414); Metal Related Pathology (4530)
Date of Event 03/07/2011
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The information in this report was provided by stryker orthopaedics legal affairs department.No additional information is available at this time due to the ongoing litigation.Should additional information become available, the evaluation summary will be submitted in a supplemental report.
 
Event or Problem Description
It was reported through the filing of a lawsuit that allegedly the patient was implanted with and lfit anatomic cocr v40 femoral head on his right hip on or about (b)(6) 2008 and was revised on (b)(6) 2011.It is further alleged that he suffered injuries as a result of implantation and explantation of the device at issue, device recall and excessive levels of chromium and cobalt in his blood.
 
Event or Problem Description
It was reported through the filing of a lawsuit that allegedly the patient was implanted with and lfit anatomic cocr v40 femoral head on his right hip on or about (b)(6) 2008 and was revised on (b)(6) 2011.It is further alleged that he suffered injuries as a result of implantation and explantation of the device at issue, device recall and excessive levels of chromium and cobalt in his blood.Additional information as per medical records received oct-16-2023: "the hip was noted to be dislocated.The femoral head was removed.This was followed by removal of a dissociated constrained liner.Constrained liner was dissociated from the head as well as the cup.".
 
Additional Manufacturer Narrative
Reported event: an event regarding abnormal ion level involving a metal head was reported.The event was not confirmed.Method & results: product evaluation and results: material analysis, visual, functional and dimensional inspections could not be performed as the device was not returned.Clinician review: a review of the provided medical records by a clinical consultant indicated: the event descriptions from the product inquiry summaries state: it was reported through the filing of a lawsuit that allegedly the patient was implanted with and lfit anatomic cocr v40 femoral head on his right hip on or about (b)(6) 2008 and was revised on (b)(6) 2011.It is further alleged that he suffered injuries as a result of implantation and explantation of the device at issue, device recall and excessive levels of chromium and cobalt in his blood.Additional information as per medical records received (b)(6) 2023: "the hip was noted to be dislocated.The femoral head was removed.This was followed by removal of a dissociated constrained liner.Constrained liner was dissociated from the head as well as the cup." the operative report dated brief operative report and sticker sheet from (b)(6) 11denote that in the revision tha performed on the acetabular liner was exchanged for a constrained liner.The operative report from a revision tha performed om (b)(6) 2017 describes that the constrained liner had dissociated from the acetabular shell, the head remained within the constrained liner.The constrained liner was revised to an adm liner that was cemented in to a well fixed protrusio cup and the head exchanged.The documentation provided confirms that a primary tha was revised for instability on (b)(6) 2011.A second revision tha surgery was performed on (b)(6) 2017 for dissociation of a constrained liner.No documentation was available to confirm excess levels of cobalt and chromium in the blood.The root cause of these tha failures cannot be determined from the limited documentation provided.Product history review: review of the device history records indicate devices were manufactured and accepted into final stock with no relevant reported discrepancies.Complaint history review: there have been no other similar events for the lot referenced.Conclussion: it was reported that the patient was revised due to excessive levels of chromium and cobalt in his blood, as per medical records received "constrained liner was dissociated from the head as well as the cup." a review of the provided medical records by a clinical consultant indicated: the event descriptions from the product inquiry summaries state: it was reported through the filing of a lawsuit that allegedly the patient was implanted with and lfit anatomic cocr v40 femoral head on his right hip on or about (b)(6) 2008 and was revised on (b)(6) 2011.It is further alleged that he suffered injuries as a result of implantation and explantation of the device at issue, device recall and excessive levels of chromium and cobalt in his blood.Additional information as per medical records received (b)(6) 2023: "the hip was noted to be dislocated.The femoral head was removed.This was followed by removal of a dissociated constrained liner.Constrained liner was dissociated from the head as well as the cup." the operative report dated brief operative report and sticker sheet from (b)(6) 2011 denote that in the revision tha performed on the acetabular liner was exchanged for a constrained liner.The operative report from a revision tha performed om (b)(6) 2017 describes that the constrained liner had dissociated from the acetabular shell, the head remained within the constrained liner.The constrained liner was revised to an adm liner that was cemented in to a well fixed protrusio cup and the head exchanged.The documentation provided confirms that a primary tha was revised for instability on (b)(6) 2011.A second revision tha surgery was performed on (b)(6) 2017 for dissociation of a constrained liner.No documentation was available to confirm excess levels of cobalt and chromium in the blood.The root cause of these tha failures cannot be determined from the limited documentation provided.Should additional information become available i would be happy to further this assessment.No further investigation for this event is possible at this time.If devices and/or additional information become available to indicate further evaluation is warranted, this record will be reopened.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
28MM +8 V40 TAPER VIT HEAD
Common Device Name
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, CEMENTED
Manufacturer (Section D)
STRYKER ORTHOPAEDICS-MAHWAH
325 corporate drive
mahwah NJ 07430
Manufacturer (Section G)
STRYKER ORTHOPAEDICS-CORK
ida industrial estate
carrigtwohill NJ NA
EI   NA
Manufacturer Contact
anna ryan
raheen business park
limerick NA
EI   NA
61498200
MDR Report Key9075197
Report Number0002249697-2019-03222
Device Sequence Number2503184
Product Code JDI
UDI-Device Identifier07613327012927
UDI-Public07613327012927
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
K173499
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2008
Device Explanted Year2011
Reporter Type Manufacturer
Report Source Other,Consumer
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/28/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/31/2013
Device Catalogue Number6260-5-328
Device Lot Number26231402
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 08/20/2019
Supplement Date Received by Manufacturer11/01/2023
Initial Report FDA Received Date09/17/2019
Supplement Report FDA Received Date11/28/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured03/21/2008
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age75 YR
Patient SexMale
-
-